Related content

Effects of adjunct glucosamine sulfate on relapsing–remitting multiple sclerosis progression: Preliminary findings of a randomized, placebo-controlled trial

By Shaygannejad Vahid   Janghorbani Mohsen   Savoj Mohammad Reza   Ashtari Fereshteh  

Neurological Research, Vol. 32, Iss. 9, 2010-11 ,pp. : 981-985

Maney Publishing

Access to resources Recommend Favorite

Stress Management and Multiple Sclerosis: A Randomized Controlled Trial

By Artemiadis Artemios K.   Vervainioti Angeliki A.   Alexopoulos Evangelos C.   Rombos Antonis   Anagnostouli Maria C.   Darviri Christina  

Archives of Clinical Neuropsychology, Vol. 27, Iss. 4, 2012-06 ,pp. : 406-416

Oxford University Press

Access to resources Recommend Favorite

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

By Collin C.   Ehler E.   Waberzinek G.   Alsindi Z.   Davies P.   Powell K.   Notcutt W.   O'Leary C.   Ratcliffe S.   Nováková I.   Zapletalova O.   Piková J.   Ambler Z.  

Neurological Research, Vol. 32, Iss. 5, 2010-06 ,pp. : 451-459

Maney Publishing

Access to resources Recommend Favorite

A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis

By Soon Derek   Altmann Daniel   Fernando Kryshani   Giovannoni Garin   Barkhof Frederick   Polman Chris   O’Connor Paul   Gray Bruce   Panzara Michael   Miller David  

Journal of Neurology, Vol. 254, Iss. 3, 2007-03 ,pp. : 306-314

Springer Publishing Company

Access to resources Recommend Favorite

Oral Zinc Sulphate Supplementation for Six Months in SCA2 Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

By Velázquez-Pérez Luis  

Neurochemical Research, Vol. 36, Iss. 10, 2011-10 ,pp. : 1793-1800

Springer Publishing Company

Access to resources Recommend Favorite